美時 (1795)
美時 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$2.77B, up 128.0% from a year earlier. EPS over the last four quarters totals NT$14.50.
Company profile
Data as of 2026-10-18
- Market
- TWSE-listed
- Industry
- Biotech & Medical Care
- Listed
- 2019-12-16
- Founded
- 1966-06-30
- Paid-in capital
- NT$2.70B
- Common shares issued
- 270,035,257
- Legal name
- 美時化學製藥股份有限公司
- Website
- http://www.lotuspharm.com.tw
Monthly revenue
Data as of 2026-10-17
| Month | Revenue | MoM | YoY |
|---|---|---|---|
| 2026-09 | NT$2.77B | +31.3% | +128.0% |
| 2026-08 | NT$2.11B | -15.4% | +81.7% |
Year to date: +74.2% vs. last year (Jan–Sep 2026)
Earnings per share (EPS)
Data as of 2026-06-30
| Quarter | EPS (NT$) |
|---|---|
| 2026 Q2 | 2.47 |
| 2026 Q1 | 2.18 |
| 2025 Q4 | 4.32 |
| 2025 Q3 | 5.53 |
| 2025 Q2 | 2.82 |
| 2025 Q1 | 5.47 |
| 2024 Q4 | 4.32 |
| 2024 Q3 | 5.98 |
Last four quarters: NT$14.50
Dividends
Data as of 2026-10-18
| Period | Cash (NT$) | Stock (NT$) | Ex-dividend | Ex-rights | Paid |
|---|---|---|---|---|---|
| 2025 年度 | 2.56 | 0.13 | — | — | — |
Shareholder structure
Data as of 2026-10-16
| Holding range | Holders | Share of total |
|---|---|---|
| 1–999 shares | 19,323 | 1.2% |
| 1,000–5,000 shares | 18,548 | 12.4% |
| 5,001–10,000 shares | 2,899 | 6.9% |
| 10,001–15,000 shares | 1,004 | 4.2% |
| 15,001–20,000 shares | 341 | 2.1% |
| 20,001–30,000 shares | 405 | 3.5% |
| 30,001–40,000 shares | 145 | 1.8% |
| 40,001–50,000 shares | 68 | 1.1% |
| 50,001–100,000 shares | 152 | 3.8% |
| 100,001–200,000 shares | 70 | 3.4% |
| 200,001–400,000 shares | 22 | 2.2% |
| 400,001–600,000 shares | 12 | 2.1% |
| 600,001–800,000 shares | 3 | 0.8% |
| 800,001–1,000,000 shares | 4 | 1.3% |
| 1,000,001+ shares | 13 | 53.2% |
TDCC data for 2026-10-16: 13 holders own more than 1,000 lots (53.2% of shares), and 19,323 hold less than one lot (1.2%).
Institutional net buying (last 20 trading days)
Data as of 2026-10-19
| Date | Foreign | Trust | Dealers | Total |
|---|---|---|---|---|
| 2026-10-19 | -294 | 0 | -53 | -347 |
| 2026-10-16 | 345 | 1 | -57 | 289 |
| 2026-10-15 | 579 | 0 | 15 | 594 |
| 2026-10-14 | 32 | 0 | -12 | 20 |
| 2026-10-13 | 52 | 0 | -18 | 34 |
| 2026-10-12 | 136 | 0 | 20 | 156 |
| 2026-10-08 | -131 | 1 | -23 | -153 |
| 2026-10-07 | 229 | 0 | 86 | 315 |
| 2026-10-06 | -147 | -1 | -18 | -166 |
| 2026-10-05 | 7 | 0 | 8 | 15 |
| 2026-10-02 | -159 | 0 | -9 | -168 |
| 2026-10-01 | -242 | 0 | 31 | -211 |
| 2026-09-30 | -43 | 0 | 10 | -33 |
| 2026-09-29 | 100 | 0 | -26 | 74 |
| 2026-09-24 | -121 | 0 | -26 | -147 |
| 2026-09-23 | 96 | 1 | 4 | 101 |
| 2026-09-22 | 2 | 0 | -6 | -4 |
| 2026-09-21 | -107 | 1 | 0 | -106 |
| 2026-09-18 | -50 | 0 | 1 | -49 |
| 2026-09-17 | 376 | 0 | 2 | 378 |
Unit: lots (1,000 shares). Over the last 20 trading days, institutions were net buyers of 592 lots.
Price (official close)
Data as of 2026-10-19
Last close NT$176.00 (2026-10-19); 52-week range NT$170.50–369.50.
Sources
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Market Observation Post System (MOPS)
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Depository & Clearing Corporation public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
- Source: Taiwan Stock Exchange and Taipei Exchange public data
Charts, drawing tools, and the P/E calculator are in the app, free to use.